Inflammatory Bowel Diseases Clinical Trials in Chapel Hill, North Carolina

4 studies are recruiting for inflammatory bowel diseases in Chapel Hill, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    040, Chapel Hill, North Carolina
    Locations
    267 in total
    Run by
    Spyre Therapeutics, Inc.

    See if you can join NCT07012395 on ClinicalTrials.gov

  2. BOOM-IBD2 Pivotal Clinical Trial

    Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tail…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    UNC Chapel Hill, Chapel Hill, North Carolina
    Locations
    19 in total
    Run by
    Boomerang Medical

    See if you can join NCT06571669 on ClinicalTrials.gov

  3. COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

    The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). Refractory means that there was no clinical response to anti-tumor necrosis factor (T…

    Stage
    Not phased
    Ages
    1 to 18
    Site
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Locations
    4 in total
    Run by
    University of North Carolina, Chapel Hill

    See if you can join NCT07198113 on ClinicalTrials.gov

  4. Feasibility Test of Action Planning in Pediatric IBD

    The goal of this interventional study is to test the feasibility of a new communication tool, call MyIBD, in youth ages 13 to 19 years with inflammatory bowel disease. The main question[s] it aims to answer are: * Is the MyIBD communication tool feasible to use in everyday clinical practice? * Does…

    Stage
    Not phased
    Ages
    13 to 19
    Site
    University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina
    Run by
    University of North Carolina, Chapel Hill

    See if you can join NCT06186752 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.